Comparison between insulin degludec/liraglutide treatment and insulin glargine/lixisenatide treatment in type 2 diabetes: a systematic review and meta-analysis

Xiaoling Cai; Xueying Gao; Wenjia Yang; Linong Ji

doi:10.1080/14656566.2017.1400011

Comparison between insulin degludec/liraglutide treatment and insulin glargine/lixisenatide treatment in type 2 diabetes: a systematic review and meta-analysis

Expert Opinion on Pharmacotherapy ◽

10.1080/14656566.2017.1400011 ◽

2017 ◽

Vol 18 (17) ◽

pp. 1789-1798 ◽

Cited By ~ 14

Author(s):

Xiaoling Cai ◽

Xueying Gao ◽

Wenjia Yang ◽

Linong Ji

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Insulin Glargine ◽

Meta Analysis ◽

Insulin Degludec

Download Full-text

Insulin Degludec, a Novel Ultra-Long-Acting Basal Insulin versus Insulin Glargine for the Management of Type 2 Diabetes: A Systematic Review and Meta-Analysis

Diabetes Therapy ◽

10.1007/s13300-019-0624-4 ◽

2019 ◽

Vol 10 (3) ◽

pp. 835-852 ◽

Cited By ~ 3

Author(s):

Wenchuan Zhou ◽

Jinxin Tao ◽

Xiaodong Zhou ◽

Hongxia Chen

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Insulin Glargine ◽

Basal Insulin ◽

Meta Analysis ◽

Insulin Degludec ◽

Long Acting

Download Full-text

Review for "Insulin glargine/lixisenatide fixed‐ratio combination ( iGlarLixi ) compared to premix or addition of meal‐time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta‐analysis"

10.1111/dom.14148/v3/review2 ◽

2020 ◽

Author(s):

CHARLES KHOURI

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Insulin Glargine ◽

Bayesian Network ◽

Basal Insulin ◽

Meta Analysis ◽

Fixed Ratio ◽

Meal Time

Download Full-text

Review for "Insulin glargine/lixisenatide fixed‐ratio combination ( iGlarLixi ) compared to premix or addition of meal‐time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta‐analysis"

10.1111/dom.14148/v2/review2 ◽

2020 ◽

Author(s):

CHARLES KHOURI

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Insulin Glargine ◽

Bayesian Network ◽

Basal Insulin ◽

Meta Analysis ◽

Fixed Ratio ◽

Meal Time

Download Full-text

Author response for "Insulin glargine/lixisenatide fixed‐ratio combination ( iGlarLixi ) compared to premix or addition of meal‐time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta‐analysis"

10.1111/dom.14148/v2/response1 ◽

2020 ◽

Author(s):

Philip Home ◽

Lawrence Blonde ◽

Sanjay Kalra ◽

Linong Ji ◽

Patricia Guyot ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Insulin Glargine ◽

Bayesian Network ◽

Basal Insulin ◽

Meta Analysis ◽

Fixed Ratio ◽

Author Response ◽

Meal Time

Download Full-text

A comparison of biphasic insulin aspart and insulin glargine administered with oral antidiabetic drugs in type 2 diabetes mellitus - a systematic review and meta-analysis

International Journal of Clinical Practice ◽

10.1111/ijcp.12337 ◽

2014 ◽

Vol 68 (3) ◽

pp. 304-313 ◽

Cited By ~ 8

Author(s):

P. Rys ◽

P. Wojciechowski ◽

S. Siejka ◽

P. Małecki ◽

Ł. Hak ◽

...

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Meta Analysis ◽

Oral Antidiabetic Drugs ◽

Biphasic Insulin ◽

Oral Antidiabetic

Download Full-text

Lower Risk of Hypoglycemia with Insulin Degludec vs. Insulin Glargine in Patients Diagnosed with Type 2 Diabetes for >10 years: Meta-Analysis of 5 Randomized Trials

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2013.08.158 ◽

2013 ◽

Vol 37 ◽

pp. S53-S54

Author(s):

Jiten Vora ◽

Helena W. Rodbard ◽

Henriette Mersebach ◽

Rahul Kapur ◽

Stewart B. Harris

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Lower Risk ◽

Randomized Trials ◽

Meta Analysis ◽

Insulin Degludec

Download Full-text

Reduced Risk of Hypoglycemia with Insulin Degludec vs. Insulin Glargine in Patients with Type 2 Diabetes and a BMI >30 kg/m2: A Meta-analysis of 5 Randomized Trials

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2013.08.166 ◽

2013 ◽

Vol 37 ◽

pp. S56

Author(s):

Helena W. Rodbard ◽

Luigi F. Meneghini ◽

David L. Russell-Jones ◽

Rahul Kapur ◽

Lars Endahl ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trials ◽

Meta Analysis ◽

Insulin Degludec ◽

Reduced Risk

Download Full-text

Lower Within-Subject Variability in Mean Blood Glucose Concentration with Insulin Degludec vs. Insulin Glargine: A Meta-Analysis of Patients with Type 2 Diabetes

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2013.08.079 ◽

2013 ◽

Vol 37 ◽

pp. S26

Author(s):

Luigi F. Meneghini ◽

Stewart Harris ◽

Marc Evans ◽

Søren Rasmussen ◽

Thue Johansen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Blood Glucose ◽

Insulin Glargine ◽

Blood Glucose Concentration ◽

Meta Analysis ◽

Insulin Degludec ◽

Subject Variability ◽

Mean Blood Glucose ◽

Within Subject Variability

Download Full-text

Review for "Insulin glargine/lixisenatide fixed‐ratio combination ( iGlarLixi ) compared to premix or addition of meal‐time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta‐analysis"

10.1111/dom.14148/v2/review1 ◽

2020 ◽

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Insulin Glargine ◽

Bayesian Network ◽

Basal Insulin ◽

Meta Analysis ◽

Fixed Ratio ◽

Meal Time

Download Full-text

Decision letter for "Insulin glargine/lixisenatide fixed‐ratio combination ( iGlarLixi ) compared to premix or addition of meal‐time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta‐analysis"

10.1111/dom.14148/v2/decision1 ◽

2020 ◽

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Insulin Glargine ◽

Bayesian Network ◽

Basal Insulin ◽

Meta Analysis ◽

Fixed Ratio ◽

Meal Time

Download Full-text